effect overlay
activetrials
Active Trials - Other
Traumatic Brain Injury (TBI)
Biomarkers for Brain Concussion

A prospective study of language function following surgical resection of left hemisphere primary brain tumours

HREC: 2015.012
Principal Investigator: A/Prof Sandy Shultz
Coordinator contact:
Funding: Non-Commercial
Active Trials - Other
Peripheral Neuropathy
Botox for Bruxism

Efficacy of Botulinum Toxin Type A in the Targeted Treatment of Nocturnal Bruxism: A Double-Blind, Randomized, Placebo-Controlled, Cross-over Study 
 

HREC: 2015.195
Principal Investigator: A/Prof Lynette Kiers
Coordinator contact: Dr Thanuja Dharmadasa
Funding: Non-Commercial
Active Trials - Other
Neuro-Ophthalmology
NODE Registry

Prospective Neuro-Ophthalmology database (NODE) towards developing comprehensive longitudinal outcome measures for neuro-ophthalmic diseases
 

HREC: 2020.336
Principal Investigator: Dr Anthony Fok
Coordinator contact:
Funding: Non-Commercial
Active Trials - Other
Huntington's Disease
WAVE 003

A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-003 Administered Intrathecally in Patients with Huntington’s Disease
 

HREC: 2020.399
Principal Investigator: Prof Dennis Velakoulis
Coordinator contact: Anice Abin
Funding: Commercial
Active Trials - Other
Huntington's Disease
Generation HD 2

A Phase II, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study to Evaluate the Safety, Biomarkers, and Efficacy of Tominersen in Individuals with Prodromal and Early Manifest Huntington’s Disease
 

HREC: 2023.014
Principal Investigator: Prof Dennis Velakoulis
Coordinator contact: Anice Abin
Funding: Commercial